Carcinogen-macromolecular adducts as biomarkers in human cancer risk assessment.
Substantial data have been generated during the past 5 years in both experimental systems and human populations which shed light on the potential role of carcinogen-macromolecular adducts in human cancer risk assessment. The use of DNA and protein adducts is based on the fundamental concept in chemical carcinogenesis that most genotoxins are metabolized to electrophilic "ultimate" carcinogens that are capable of forming covalent adducts with cellular macromolecules. This report examines the relative usefulness and limitations of using DNA and protein adducts and related techniques for assessing human exposure to genotoxic carcinogens. Data discussed in this report clearly demonstrate that these biomarkers not only allow early detection of potential cancer hazard in humans, but they can also significantly increase the power of conventional cancer epidemiological studies in determining true causal relationships. In addition, such biomarkers can improve extrapolation of cancer risks from laboratory animals to humans or from one human population to another.
Hsia
M T
MT
Toxic and Hazardous Materials Assessment and Control, Energy, Resources and Environmental Systems Division, MITRE Corporation, McLean, Virginia 22102.
D015415:Biomarkers; D002273:Carcinogens / Q000378:metabolism*; D004249:DNA Damage; D006801:Humans; D009369:Neoplasms / Q000139:chemically induced / Q000378:metabolism; D012307:Risk Factors
D015415:Biomarkers; D002273:Carcinogens